Treatment guidelineExperimental Treatments

Treatment guideline

In the dynamic field of dermatology, there is growing interest in experimental treatments for vitiligo. Experienced dermatologists often consider these novel approaches, either due to their unique availability in certain regions or because their potential benefits may surpass the associated risks.

However, approaching these treatments requires careful consideration. Drugs like azathioprine, HSP70i, prostaglandin, pseudocatalase, 5-fluorouracil, methotrexate, methylprednisolone, mynocycline, and simvastatin show promise in treating vitiligo. Yet, there's still a lack of clear understanding regarding who the ideal candidates for these treatments are and their comprehensive safety profiles. This uncertainty necessitates a cautious approach, balancing the potential for significant benefits against the unknown risks.



FAQOther Questions

  • Who is prone to vitiligo?

    Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...

  • What are risks of oral and topical corticosteroids?

    Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...

  • What tests for vitiligo should be done?

    Before starting vitiligo therapy, several tests may be recommended to ensure an accurate diagnosis and appropriate treatment plan: Physical Examination A thorough physical exa...